Autophagy is a highly regulated catabolic process that involves sequestration and lysosomal degradation of cytosolic components such as damaged organelles and misfolded proteins. While autophagy can be considered to be a general cellular housekeeping process, it has become clear that it may also play cell type-dependent functional roles. In the present study we analyzed the functional importance of autophagy in human hematopoietic stem/progenitor cells (HSPCs), and how this is regulated during differentiation. Western blot-based analysis of LC3-II and p62 levels, as well as flow cytometry-based autophagic vesicle quantification, demonstrated that umbilical cord blood (UCB)-derived CD34 + /CD38immature hematopoietic progenitors show a higher autophagic flux than CD34 + /CD38 + progenitors and more differentiated myeloid and erythroid cells. This high autophagic flux was critical for maintaining stem and progenitor function since knockdown of autophagy genes ATG5 or ATG7 resulted in reduced HSPC frequencies in vitro as well as in vivo. This reduction in HSPCs was not due to impaired differentiation, but at least in part due to reduced cell cycle progression and increased apoptosis. This is accompanied by increased expression of p53, pro-apoptotic genes BAX and PUMA, and the cell cycle inhibitor p21, as well as increased levels of cleaved caspase-3 and reactive oxygen species (ROS).
Introduction
Autophagy is a highly regulated catabolic process that involves sequestration and lysosomal degradation of cytosolic components such as damaged organelles including mitochondria, endoplasmic reticulum (ER) and peroxisomes, and misfolded proteins [1] [2] [3] [4] . While autophagy can be considered to be a general cellular housekeeping process, it has become clear that it may also play cell type-dependent functional roles. Autophagic flux may be increased under stress conditions such as starvation, energy limitation, hypoxia and DNA damage [5] . Also, when cells are preparing to undergo structural remodeling such as the developmental transitions observed during erythropoiesis, the process of autophagy is upregulate [6 ] . Autophagy is characterized by the formation of double membrane vesicles called autophagosomes that after engulfing cellular components fuse with lysosomes resulting in degradation of cargo. Critical components of the autophagy pathway include ATG5 and ATG7, which are involved in the elongation and closure of the autophagosomal membrane [3, 5] . Preliminary studies, mostly in animal models, have suggested a potential role for autophagy in hematopoietic cell function [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . Autophagy has been shown to be involved in erythroid differentiation during structural alterations in progenitor cells, as an essential process for mitochondria and ribosome clearance [8] [9] [10] [11] [12] [13] [14] and as a pro-survival mechanism during human monocyte-macrophage differentiation [15] . In addition, conditional deletion of the autophagy protein FIB200 in murine hematopoietic stem cells (HSCs) resulted in HSC depletion, loss of HSC reconstituting capacity, and a block in erythroid maturation [16] . Moreover, an aberrant expansion of myeloid cells associated with an increase in mitochondrial mass and reactive oxygen species (ROS) was observed. [16] . Furthermore, using an Atg7 conditional knockout mouse model, Mortensen et al. showed that LSK (lineage negative, Sca-1 positive, c-kit positive) cells accumulate aberrant mitochondria, increased levels of reactive oxygen species (ROS), and show excessive DNA damage resulting in loss of HSCs [17] .
Despite this, little is known concerning the regulation of autophagy in human HSCs and their progenitors, and most importantly how this may be regulated during hematopoiesis.
In the present study, we examined the role of autophagy in human umbilical cord blood-derived HPSCs. Our data demonstrate a higher autophagic flux in CD34 + HSPCs compared to CD34myeloid and erythroid progenitors. Furthermore, knockdown of ATG5 or ATG7 resulted in a marked decrease in HSPC frequencies, which coincided with a strong reduction in expansion upon myeloid/erythroid differentiation. We show that the reduction in HSPC expansion was not due to impaired differentiation, but rather due to reduced cell cycle progression and increased apoptosis. This is accompanied by increased PUMA, BAX, p21 and p53 expression, and an increase in both cleaved caspase-3 and reactive oxygen species (ROS). Taken together, our data suggest that autophagy is crucial for human HSPC maintenance by reducing cellular stress and promoting survival.
Materials and Methods

Antibodies and reagents
The following anti-human antibodies were used: mouse anti-SQSTM1/p62 (sc-28359) and goat anti-actin (sc16160) from Santa Cruz (Santa Cruz, CA, USA), rabbit anti-cleaved caspase-3 (Asp175) (9661) and rabbit anti-Atg7 (8558), from Cell Signaling Technologies (Boston, MA, USA). Mouse anti-LC3 (5F10, 0231-100) was from Nanotools (Munich, Germany), rabbit anti-Histone H3 (06-755) from Millipore (Billerica, Massachusetts, USA), mouse anti-ATG5 (ab108327) from abcam ( Cambridge, UK) and rabbit anti-HSP90 from Ineke Braakman lab (Utrecht, The Netherlands). Peroxidase-conjugated secondary antibodies were from Dako (Santa Clara, CA, USA). Hydroxychloroquine (HCQ), Bafilomycin A1 (BafA1), Cycloheximide (CHX) were obtained from Sigma-Aldrich (Saint Louis, MI, USA). Rapamycin (Rap) was from Enzo Life Sciences (Farmingdale, New York, USA).
Isolation and culture of human CD34 + cells
Umbilical cord blood (UCB) was obtained from healthy full-term pregnancies, from the obstetrics departments at the Martini Hospital, the University Medical Center Groningen (Groningen, The Netherlands) and the Wilhelmina Children's Hospital (Utrecht, The Netherlands). All studies were after performed informed consent and protocol approval by the Medical Ethical Committee of the UMCG and UMCU in accordance with the Declaration of Helsinki. Mononuclear cells (MNC) were isolated from UCB by density centrifugation over a Ficol-Paque solution (density 1.07 g/mL). CD34 + cells were isolated by Mini-Macs or the autoMACS pro-separator (Miltenyi Biotec, Amsterdam, The Netherlands). CD34 + cells were cultured in Hematopoietic Progenitor Growth Medium from Lonza (Basel, Switzerland) supplemented with 100 units/mL of penicillin, 100 mg/mL of streptomycin (Gibco), stem cell factor (SCF) (50-100 ng/mL), fms-like tyrosine kinase-3 ligand (FLT-3) (50-100 ng/mL), and thrombopoietin (TPO) (10-100 ng/ mL) to a density of 5 x 10 5 cells/mL. [18] [19] [20] Liquid cultures and MS5 co-cultures CD34 + cells were differentiated towards neutrophils over 17 days upon addition of SCF (50 ng/mL), FLT-3 ligand (50 ng/mL), 0.1 nmol/L of granulocyte macrophage colony-stimulating factor (GM-CSF), interleukin 3 (IL-3) (0.1 nmol/L) and granulocyte colony-stimulating factor (G-CSF) ( 
Flowcytometry analysis
After isolation, CD34 + cells were resuspended in PBS / 5% FCS (Hyclone, GE Healthcare, South Logan, Utah, USA) and subsequently incubated for 30 min at 4°C with anti-human CD34, CD38, CD45RA and CD90. After incubation, cells were washed and incubated for 30 min at 37˚C using Cyto-ID Autophagy Detection dye (ENZ-51031-0050, Enzo Life Sciences). The cells were subsequently washed and analyzed by FACSflow cytometric analysis (FACS). The same procedure was used during myeloid, neutrophil, and erythrocyte differentiation, where the following antibodies were used: anti-CD14, anti-CD15, anti-CD33, anti-CD11b anti-CD16, anti-CD71 and anti-CD235a (Glycophorin A) (additional information can be found in Supplemental Table 1 ). All data was analyzed using FlowJo (Tree Star, Oregon, USA) software.
Cell cycle analysis, apoptosis & ROS measurements
Cell cycle analysis was performed by staining cells in 5mg/ml Hoechst 33342 
Lactoferrin staining
After 17 days of neutrophil differentiation, cells were fixed in 100 µL 0.5% formaldehyde for 15 minutes at 37˚C, after the cells were permeabilized in 900 µL of ice-cold methanol for 30 minutes on ice. Cells were subsequently washed with PBS, resuspended in PE-conjugated lactoferrin antibody (Immunotech, Vaudreuil-Dorion, QC, Canada) and incubated for 25 minutes. Cells were again washed and flow cytometric analysis was performed.
Virus production and transduction of CD34 + cells
Validated shATG7 (TRCN0000007586, Sigma-Aldrich) and shATG5
(TRCN0000151474, Sigma-Aldrich) targeting the coding region of ATG7 (GCTTTGGGATTTGACACATTT) and ATG7 (CCTTTCATTCAGAAGCTGTTT) were 94 described by Mitter et al. [22] and Maycotte et al. [23] . The vectors were cloned into PLKO.1-GFP and PLKO.1-mcherry using MunI and SacII restriction enzymes.
The shP53 sequence, as described by Brummelkamp et al. [24] , was cloned into pLKO.1-mCherry. An shRNA sequence that does not target human genes (referred to as scrambled) was used as control. Table 2 .
CFC and LTC-IC assay
For colony-forming cell (CFC) assay, 500 transduced CD34 + cells or 25,000 cells derived from culture, were plated in duplicate in 1 mL methylcellulose (H4230, with new medium on a weekly basis. After five weeks, the medium was removed and replaced with methylcellulose supplemented with the same cytokines as listed above. After an additional two weeks, wells were scored as positive or negative for CFC. LTC-IC frequencies were calculated using L-Calc software [20] (Stem Cell Technologies).
In vivo transplantations into NSG mice
Twelve-to thirteen -week-old female NSG (NOD.Cg-Prkdcscid IL2rgtm1Wjl/SzJ) mice were purchased from the Central Animal Facility breeding facility within the UMCG. Mouse experiments were performed in accordance with national and institutional guidelines and all experiments were approved by the Institutional Animal Care and Use Committee of the University of Groningen (IACUC-RuG). Experiments were performed in general as described previously [25, 26] and the detailed experimental approach is described in the Supplementary Methods.
Histochemical staining of hematopoietic cells
May-Grunwald Giemsa staining was used to analyze myeloid differentiation.
Cytospins were prepared from 5.0 x 10 4 differentiating granulocytes and were fixed in methanol for 3 minutes. After fixation, cytospins were stained in a 50% eosin methylene blue solution according to May-Grunwald (Sigma Aldrich) for 
Statistical analysis
Unpaired two-sided student's test was used to calculate statistical differences. A P-value of <0.05 was considered statistically significant.
Results
CD34 + HSPCs have an increased autophagic flux compared to CD34myeloid progenitors
To investigate the relative levels of autophagy in human umbilical cord blood (UCB) CD34 + hematopoietic cells, LC3-II levels were first analyzed by Western blot. LC3-I is a cytosolic ubiquitin-like protein that is converted during autophagy to a lipidated form (LC3-II) which is associated with autophagosomal membranes [15, 27] . An increase in LC3-II is not a measure of autophagic flux per se, since it can also indicate an inhibition of autophagosome clearance [3] . Therefore, cells were also treated with bafilomycin A1 (BafA1) to prevent lysosomal degradation and to block the fusion of autophagosomes with lysosomes [28] . Accumulation of p62 also known as Sequestosome-1 (SQSTM1) was additionally used to monitor autophagic flux.
p62 is an ubiquitin-binding scaffold protein that binds directly to LC3-II and is exclusively degraded during autophagy. Thus, p62 accumulates when autophagy is inhibited, and decreased levels can be observed when autophagy is induced [29] .
In the absence of BafA1, CD34 + cells showed undetectable levels of LC3-II protein (Fig. 1A) ; however upon BafA1 treatment, levels increased dramatically. In contrast, untreated CD34myeloid progenitors already demonstrated detectable LC3-II levels that increased only modestly upon BafA1 treatment (Fig. 1B) . The ratio of LC3-II levels between BafA1 treated and untreated cells, a measure of autophagic flux, was far greater in CD34 + cells when compared to CD34myeloid progenitors (CD34 + cells 6.23 ± 1.57 vs. CD34myeloid progenitors 1.18 ± 0.15 (P<.05)) ( Fig. 1C) .
Similar results were observed when monitoring p62 accumulation, changes in p62 protein levels between untreated and BafA1-treated cells were higher in CD34 + HSPCs than in CD34myeloid progenitor cells ( Fig. 1A-C ). In addition, degradation of p62 was monitored after inhibition of protein translation using cycloheximide. While p62 degradation in CD34 + HSPCs was visible after one hour of the treatment (Fig. 1D) , p62 levels in CD34myeloid progenitors were only decreased after three hours of cycloheximide treatment and to a much lower level. Taken together these results suggest that autophagic flux is more efficient in CD34 + HSPCs than in CD34myeloid progenitors.
To further validate these observations, CD34 + cells were also treated for three hours (instead of overnight) with either BafA1, or with hydroxychloroquine (HCQ), an additional inhibitor of lysosomal function. Changes in LC3-II levels were similar between CD34 + cells whether treated with BafA1 for three hours (Supplemental . 1B) . Furthermore, survival cytokine levels were not found to influence autophagy, since LC3-II levels did not change with increasing cytokine concentrations (Supplemental Fig. 1C ).
To further confirm increased autophagic flux in CD34 + HSPCs as compared to CD34 - myeloid progenitors, the autophagic vacuole content of these cells was analyzed by flow cytometry using Cyto-ID, a dye selectively labelling autophagic vacuoles [30, 31] . Co-localization of LC3-II puncta with Cyto-ID staining, and increased accumulation of Cyto-ID upon treatment with BafA1 and rapamycin (an inducer of autophagy 32,33) were used to validate this dye (Supplemental Fig. 2) . Flow cytometric analysis revealed an increased accumulation of autophagic vacuoles in CD34 + HSPCs after BafA1 treatment as compared to more differentiated CD34myeloid progenitors (CD34 + cells 2 ± 0.17 vs. CD34myeloid progenitors 1.1 ± 0.01) (P<.001) ( Fig. 1E) . Taken together, these data confirm the higher autophagic flux in CD34 + HSPCs compared to CD34myeloid progenitors.
To determine the levels of autophagic flux during HPSC differentiation, CD34 + cells were differentiated in vitro towards both the myeloid and erythroid lineages and LC3-II protein levels analyzed by Western blot ( Fig. 2A) . First, the differentiation status was confirmed by cytospin and analysis of cell surface markers (Supplemental Fig. 3A-B) . Throughout myeloid differentiation LC3-II levels did not increase after BafA1 treatment. In contrast, at an early time point during erythroid differentiation (day 7) a consistent increase in LC3-II levels was observed after BafA1 treatment, while at a later time point (day 11) no difference was measured, suggesting a general reduction in autophagic flux during both myeloid and erythroid differentiation. To confirm this, autophagic flux was evaluated during myeloid and erythroid differentiation by Cyto-ID analysis (Fig.   2B ). Again, a higher autophagic flux was observed in CD34 + cells compared to in vitro matured myeloid and erythroid cells (CD34 + cells day 1: 2.09 ± 0.19, myeloid progenitors day 7: 1.06 ± 0.02, and at day 14: 1.05 ± 0.02, erythroid progenitors day 7: 1.49 ± 0.34 and at day 11: 0.98 ± 0.1 (P<0.05)).
Autophagic flux was also analyzed in freshly isolated marker-defined UCB-derived stem and progenitor fractions. The CD34 + CD38 -CD45RA -CD90 + highly enriched HSC population showed a higher autophagic flux compared with CD34 + CD38 + multipotent progenitors ( Fig. 2C and Supplemental Fig. 3C ). However, there were no differences when compared to CD34 + CD38 -CD45RA -CD90cells (CD34 + CD38 -CD45RA -CD90 + 2.7 ± 0.97 fold, CD34 + CD38 -CD45RA -CD90 -2.5 ± 0.81 fold CD34 + CD38 + 2.3 ± 0.1 fold, (P<.023)). In contrast, more mature CD33 + or CD14 + myeloid cells or CD71 bright CD235 + erythroid cells showed only marginal HQCinduced autophagic vacuole accumulation, while CD71 -CD235 + erythroid cells showed a HQC-induced autophagic vacuole accumulation (CD33 + 1.15 ± 0.09, 99 CD14 + 1.22 ± 0.06, CD71 bright CD235 + 1.12 ± 0.15, CD71 -CD235 + 1.51 ± 0.05) ( Fig. 2D and   Supplemental Fig. 3D ). Taken together, these results indicate that HSPCs have a higher basal autophagic flux compared to more differentiated progenitor cells of the myeloid or erythroid lineage.
Reduction of autophagy in human CD34 + HSPCs results in a decrease of the hematopoietic stem/progenitor pool
To investigate the functional role of autophagy in HSCs and their progeny, human CD34 + cells were transduced with previously validated [22, 23, 34, 35] . lentiviral shRNAs, targeting the coding region of ATG5 (shATG5) or ATG7 (shATG7).
Lentiviral-mediated knockdown of ATG5 and ATG7 resulted in 80% (P<.01) and 70% (P<.01) reduced mRNA expression respectively, as compared to a scrambled shRNA control (shSCR) (Fig. 3A) . In addition, knockdown of ATG5 does not affect mRNA levels of ATG7 and vice versa. (Supplemental Fig. 4A) . A reduction in ATG5 and ATG7 protein levels was also observed on Western blot (Fig. 3B) .
The knockdown of either ATG5 or ATG7 resulted in a significant reduction in the erythroid progenitor (BFU-E) frequencies (shSCR 126.5 ± 9 vs. shATG5 57.5 ± 5
(P<.05) or shATG7 90 ± 1.4 (P<.05)) ( Fig. 3C) . Since both shRNAs phenocopy the effects on progenitor frequencies this also excludes the possibilities of having off-target effects.
In contrast, no reduction in myeloid progenitor cell (CFU-GM) frequencies were observed. Next, shATG5-and shATG7-transduced CD34 + cells were cultured in vitro under liquid culture conditions driving myeloid or erythroid differentiation.
Under myeloid conditions knockdown of ATG5 or ATG7 resulted in a significant reduction in cell expansion (shATG5 17.9 fold (P<.05) or shATG7 12.3 fold (P<.05)) ( Fig. 3D) . Likewise, expansion under erythroid permissive conditions was reduced (shATG5 6.7 (P<.05) or shATG7 1.7 fold (P<.05)) ( Fig. 3D) . Cell morphology analysis and flow cytometry-based analysis of expression of the myeloid differentiation markers CD14 and CD15 (Supplemental Fig. 4C ) and the erythroid differentiation markers CD71 and CD235A (Supplemental Fig. 4D ) revealed that ATG5 or ATG7 knock-down did not lead to a block in differentiation. In addition, CFC assays to measure progenitor frequencies present in the myeloid liquid cultures revealed a reduction in myeloid progenitors (CFU-GM) frequencies at day 7 (shSCR 78 ± 16 vs. shATG5 25 ± 4 (P<.05) or shATG7 53.5 ± 5)) ( Fig. 3E ) and day 14 (shSCR 25.5 ± 2 vs. shATG5 5.0 ± 0 (P<.01) or shATG7 17.5 ± 8) . At day 7 or 14 of erythroid liquid culture, BFU-E colonies were hardly observed suggesting that cells had already differentiated beyond the progenitor stage at these time points (data not shown). To study the long-term effects of ATG5 or ATG7 knock-down on CD34 + cells, transduced CD34 + HSPCs were cultured for four weeks on an MS5 stromal layer.
In accordance with data obtained from liquid cultures, ATG5 or ATG7 knockdown also resulted in reduced expansion in these stromal co-cultures (shATG5 2.8 (P<.05) and shATG7 1.7 fold (P<.05)) ( Fig. 4A) . This coincided with a significant reduction in CFU-GM frequencies of shATG5-transduced CD34 + cells (Fig. 4B) . Furthermore, the primitive hematopoietic cells, as defined in long term culture initiating cell (LTC-IC) assays, were at least 3-fold reduced upon down regulation of ATG5 or ATG7 (shATG5 4.1 (P<.01) and shATG7 3.1 fold (P<.05)) ( Fig. 4C) . To assess whether ATG5 and ATG7 knockdown also affected in vivo engraftment, unsorted shSCR, shATG5, or shATG7-mCherry transduced UCB CD34 + cells were transplanted in immunodeficient NSG mice, as outlined in Fig. 5A . Transplanted CD34 + cells were ~60% mCherry positive. (Fig. 5B and Supplemental Fig. 5A) . The knockdown of ATG5 and ATG7 in the mCherry positive fraction of the injected cells was confirmed by qPCR of cells grown in vitro for 7 days in a liquid culture assay ( Fig. 5C) . Engraftment as determined by the percentage huCD45 in peripheral blood, was significantly reduced in shATG5/7 mice compared to control (Fig. 5D,   left panels and Supplemental Fig. 5B) . While mCherry levels for shSCR were stable around ~60%, the contribution of the shATG5 and shATG7 transduced cells to the engrafted cells was significantly reduced at week 12 (Fig 5D. Right panels) .
Representative FACS plots of analysis at week 12 are shown in Fig. 5E . Together, these findings demonstrate the essential role of autophagy in the maintenance of both the progenitor and HSC compartment of UCB CD34 + cells.
Decreased autophagy results in reduced cell cycle entry, intracellular ROS and apoptosis levels
To understand the molecular mechanisms underlying the effects observed after down-regulation of ATG5 or ATG7 we used Hoechst to perform flow cytometrybased cell-cycle analysis. At day 5 of the myeloid liquid culture assay a small but significant reduction in the percentage of cells in S phase was observed in cells where ATG5 or ATG7 were knocked-down (shSCR 21.8 ± 0.4 vs. shATG5 16.1 ± 1.9 (P<.01) or shATG7 16.4 ± 1.1 (P<.01) (Fig. 6A) . This coincided with a marked increase in mRNA expression of cell cycle-dependent kinase inhibitor p21 (shATG5 2.2 fold ± 0.1 (P<.01) and shATG7 2.8 fold ± 0.2 (P<.01)) ( Fig. 6B) . Since autophagy is known to be intimately connected with the apoptosis machinery, we also determined whether apoptosis was affected upon ATG5 or ATG7 knockdown. Under myeloid permissive conditions an increase of Annexin-V positive cells was observed upon both ATG5 and ATG7 knockdown (day 4: shSCR 11.4 % ± 4.3 vs. shATG5 35.4 ± 6.1 (P<.01) or shATG7 24.8 % ± 7.1 (p<.05)) ( Fig. 6C) . Under erythroid permissive conditions, surprisingly only a reduction in ATG7 levels resulted in an increased percentage of Annexin-V positive cells (day 4: shSCR 16.6% ± 1.6 vs shATG7 27.8% ± 5.0 (p <0.05)) (Fig 6D) .
Upon knockdown of ATG5 in freshly isolated UCB-derived CD34 + or NB4 cells an increase in cleaved caspase-3 was observed ( Fig. 6E and Supplemental Fig.   6 ). In line with the increased apoptosis after ATG5 and ATG7 knockdown, mRNA expression levels of p53 were increased during both myeloid and erythroid liquid culture, as well as pro-apoptotic BAX, PUMA and putative PKB/c-akt inhibitor PHLDA3 [36] (Fig. 6F) . Furthermore, knockdown of p53 in conjunction with shATG5 or shATG7 resulted in a partial rescue of cell growth (shATG5: 41.2% and shATG7: 37.3% rescue respectively) (Supplemental Fig. 7) . To investigate the possible mechanism underlying this increase in pro-apoptotic gene expression, ROS levels were measured by means of H2DCFDA after ATG5 or ATG7 knockdown ( Fig. 6G) . ATG5 and ATG7 knockdown cells show elevated intracellular ROS levels compared to control cells (shSCR 1 ± 0.15 vs shATG5 1.3 ± 0.2 (P<.05) or shATG7 1.2 ± 0.1 (P<.05)). Furthermore, when cells were treated with hydrogen peroxide (H2O2), ROS levels were also higher for ATG5 and ATG7 knockdown cells Furthermore, when cells were treated with hydrogen peroxide (H2O2), ROS levels were also higher for ATG5 and ATG7 knockdown cells (shSCR 1 ± 0.12 vs. shATG5 1.5 ± 0.2 (P<.05) or shATG7 1.3 ± 0.18 (P<.05)) suggesting an inability to cope with increased ROS-levels in autophagy-defective HSPCs. Taken together these data indicate that reduced autophagy results in a decrease of the hematopoietic stem and progenitor pool, due to decreased proliferation and induction of apoptosis that may be, at least in part, attributed to increased intracellular ROS levels.
Discussion
Over the last decade it has become increasingly clear that autophagy is essential As long-lived cells, the high autophagic flux in HSPCs likely acts as a homeostatic quality control mechanism for the preservation of cellular integrity [7, [37] [38] [39] [40] .
These findings are also in line with higher expression of ABC transporters in primitive HSPCs in comparison with differentiated cells [41, 42] . Warr et al. have shown that murine HSCs exhibit autophagy flux only after cytokine deprivation [43] . In contrast, Leveque-El Mouttie et al. have demonstrated that LKS + cells have an increase in LC3-GFP puncta after mice were treated with granulocyte-colony stimulating factor (G-CSF) [44] . However, samples from clinical stem cell donors pre-and post-G-CSF mobilization show inconsistent changes in LC3-II protein levels [44] . In our experimental setup, which involves the use of human rather than murine HSPCs, cytokine concentrations did not influence autophagic flux.
This suggests that the high autophagic flux observed is an intrinsic property of human HSPCs [4] . Larger body size increases the proliferative demand on human stem and progenitor cells compared to mice and longer lifespan in humans increases the risk of accumulating DNA damage [45] . These may help to explain why human HSPCs would require additional protective mechanisms.
Even though autophagic flux in human HSPCs is higher compared to differentiated cells, erythroid progenitors also show increased autophagic flux during differentiation as determined by LC3-II and autophagosome quantification. This enhanced autophagic flux has been implicated to be a pre-requisite for the formation of mature erythrocytes by contributing to the process of enucleation and elimination of mitochondria [13] [14] [15] . In contrast, during neutrophil differentiation there was a clear reduction in autophagic flux which results in a decrease of LC3-II protein levels at the last day of differentiation. In accordance with these observations, Rozman et al. have demonstrated that murine Atg5-deficient neutrophils show no evidence of abnormalities in morphology, protein content and apoptosis regulation but rather increased proliferation [46] . Our results show that autophagy seems to be dispensable for human neutrophil development but important for the formation of mature erythrocytes.
The decrease in HSPC proliferation observed after knockdown of ATG5 and ATG7 is accompanied by decreased cell cycle progression and increased apoptosis.
In agreement with our findings, Cao et al. has recently shown that a defect in autophagy disrupts the quiescence and cell cycle of murine HSPCs [47] . By using a conditional autophagy-defective mouse model (Atg7f/f; Vav-Cre) where ATG7 is knockout in hematopoietic populations, it was observed that atg7 -/-HSPCs show a reduction of G0/G1 cells and an increase of G2/M cells. This was accompanied with a decrease in cell numbers and an increase in apoptosis [47] . However, it is important to consider that the use of Vav-Cre could also affect vascular endothelial cells which might indirectly affect hematopoiesis, in particular HSC quiescence in bone marrow vascular endothelial niches [48] .
In addition, inhibition of starvation-induced autophagy by 3-MA (an inhibitor targeting class III PI3K) but not by Bafilomycin-A1, enhanced G1/S transition of HSPCs and resulted in an accumulation of cyclin D3 [47] . This suggests that upon nutrient stress, early signaling events of autophagy may prevent HSPCs entering the cell cycle as a protective mechanism.
Our results suggest that inhibition of G0/S transition and increased cell death in HSPCs after knockdown of ATG5 and ATG7 are due to an upregulation of p53, p21, PHLDA3, BAX and PUMA. The p53 tumor suppressor gene plays a role in the regulation of cellular stress response through the activation of genes involved in cell cycle including p21, and apoptosis such as PHLDA3, BAX and PUMA.
Even though mRNA levels of p53 and its target genes were upregulated after knockdown of ATG5 and ATG7, additional experiments to evaluate whether there is an increase in p53 activity would be relevant. However, we did observe that knockdown of p53 could rescue the negative phenotype induced by loss of ATG5 or ATG7, further strengthening the hypothesis that inhibition of autophagy triggers a p53-dependent stress responds.
We have shown that after knockdown of ATG5 and ATG7 in HSPCs there is an increase in the expression of BAX and PUMA that may be due to the increase of p53 expression. BAX is a Bcl-2 family member that has been reported to increase mitochondrial membrane permeability [49] . while PUMA is part of the BH3-only
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Bcl-2 family protein that when overexpressed causes cytochrome-C release from the mitochondria resulting in induction of an apoptotic program [50]. The increase in ROS observed after loss of autophagy in HSPCs could be in part due to the activation of BAX and PUMA since the accumulation of ROS in response to p53 has been shown to be markedly reduced in the absence of these genes 
Conclusions
Taken together, our data suggest that autophagy is an important housekeeping mechanism for human umbilical cord blood-derived CD34 + cells and that its inhibition results in cellular stress. A constant high autophagic flux appears indispensable for the maintenance of healthy HSPCs, thus when autophagy is impaired, cells undergo cell cycle arrest and apoptosis (in a p53-dependent manner) to avoid risking the integrity of the hematopoietic system. Our findings may serve as basis for the development of novel approaches involving autophagy activation for the expansion and maintenance of transplantable HSCs in vitro.
Supplemental Figure 1. Differences in LC3-II content are not due to changes in cell survival or in the levels of survival cytokines. (A)
Western blot comparing LC3-II and p62 levels of CD34 + cells after three hours treatment with BafA1 (20 nm) or HCQ (20 nM). (B) CD34 + cells treated for overnight with BafA1 (20 nM) and HCQ (20 µM). Apoptosis quantification by FACS using Annexin V. (C) CD34 + cells were cultured with 50 ng/mL of SCF, 50 ng/mL FLT-3 and 10 ng/mL of TPO (+) and with 500 ng/mL of SCF, 500 ng/mL FLT-3 and 100 ng/mL of TPO (++) in the presence or absence of BafA1 (20 nM). Western blot comparing LC3-II and p62 levels. All experiment were done in biological triplicates.
Supplemental Figure 2. Cyto-ID staining is specific for autophagic vesicles. (A)
Hela cells were transfected with LC3-RFP and treated with BafA1 (200 nM) and Rap (20 nM). After, cells were incubated with the Cyto-ID dye and were visualized with the deltavision microscope with 40x magnification. Note, not all cells are successfully transfected with LC3-RFP, hence not all cells contain red staining. In the successfully transfected cells there is a high overlap with Cyto-ID staining in green. Experiment done in biological duplicates 
